Marinus Pharmaceuticals (MRNS) Stock: Climbing On Positive Clinical Data
Marinus Pharmaceuticals Inc (NASDAQ: MRNS) is having a great start to the trading session this morning, and for good reason. The company announced positive clinical data, exciting investors and sending the stock screaming for the top. Today, we’ll talk about: The positive clinical data; what we’re seeing from MRNS as a result; and what we’ll … Read more